Germany · Delayed Price · Currency is EUR Vitruvia Medical AG Statistics
Total Valuation
MUN:991 has a market cap or net worth of EUR 1.77 million. The enterprise value is 2.92 million.
| Market Cap | 1.77M |
| Enterprise Value | 2.92M |
Important Dates
The last earnings date was Friday, September 12, 2025.
| Earnings Date | Sep 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MUN:991 has 2.31 million shares outstanding.
| Current Share Class | 2.31M |
| Shares Outstanding | 2.31M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.01 |
| PB Ratio | -3.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.46 |
| EV / Sales | 1.66 |
| EV / EBITDA | 47.88 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.68
| Current Ratio | 0.68 |
| Quick Ratio | 0.54 |
| Debt / Equity | n/a |
| Debt / EBITDA | 20.34 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -13.85% |
| Return on Invested Capital (ROIC) | -217.81% |
| Return on Capital Employed (ROCE) | -49.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MUN:991 has paid 30,800 in taxes.
| Income Tax | 30,800 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +70.00% in the last 52 weeks. The beta is 1.93, so MUN:991's price volatility has been higher than the market average.
| Beta (5Y) | 1.93 |
| 52-Week Price Change | +70.00% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 0.99 |
| Relative Strength Index (RSI) | 2.91 |
| Average Volume (20 Days) | 148 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MUN:991 had revenue of EUR 1.76 million and -535,435 in losses. Loss per share was -0.23.
| Revenue | 1.76M |
| Gross Profit | 1.30M |
| Operating Income | -370,511 |
| Pretax Income | -504,635 |
| Net Income | -535,435 |
| EBITDA | 61,077 |
| EBIT | -370,511 |
| Loss Per Share | -0.23 |
Balance Sheet
The company has 85,421 in cash and 1.24 million in debt, giving a net cash position of -1.16 million or -0.50 per share.
| Cash & Cash Equivalents | 85,421 |
| Total Debt | 1.24M |
| Net Cash | -1.16M |
| Net Cash Per Share | -0.50 |
| Equity (Book Value) | -500,346 |
| Book Value Per Share | -0.22 |
| Working Capital | -215,342 |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 73.92%, with operating and profit margins of -21.08% and -30.46%.
| Gross Margin | 73.92% |
| Operating Margin | -21.08% |
| Pretax Margin | -28.71% |
| Profit Margin | -30.46% |
| EBITDA Margin | 3.47% |
| EBIT Margin | -21.08% |
| FCF Margin | n/a |
Dividends & Yields
MUN:991 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.55% |
| Shareholder Yield | -36.55% |
| Earnings Yield | -30.29% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MUN:991 has an Altman Z-Score of -11.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.79 |
| Piotroski F-Score | 3 |